These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 28234436

  • 1. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H, Lee J, Fervaha G, Foussias G, Agid O, Remington G.
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [Abstract] [Full Text] [Related]

  • 3. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [Abstract] [Full Text] [Related]

  • 4. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P.
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [Abstract] [Full Text] [Related]

  • 5. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ, Reinbold H, Lemanski S, Basilowski M, Juckel G.
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [Abstract] [Full Text] [Related]

  • 7. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC, Chiu HJ, Chen JY, Liou YJ, Wang YC, Chen TT, Bai YM.
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [Abstract] [Full Text] [Related]

  • 8. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL.
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [Abstract] [Full Text] [Related]

  • 9. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [Abstract] [Full Text] [Related]

  • 10. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [Abstract] [Full Text] [Related]

  • 11. Double-blind study of clozapine dose response in chronic schizophrenia.
    Simpson GM, Josiassen RC, Stanilla JK, de Leon J, Nair C, Abraham G, Odom-White A, Turner RM.
    Am J Psychiatry; 1999 Nov; 156(11):1744-50. PubMed ID: 10553738
    [Abstract] [Full Text] [Related]

  • 12. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D, Bartko JJ.
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [Abstract] [Full Text] [Related]

  • 13. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA.
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [Abstract] [Full Text] [Related]

  • 14. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR, Marder SR, Chengappa KN, Petrides G, Ames D, Wirshing WC, McMeniman M, Baker RW, Parepally H, Umbricht D, Kane JM.
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [Abstract] [Full Text] [Related]

  • 15. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS, Ahn YM, Park HJ, Lee KY, Kim SH, Kang UG, Kim YS.
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [Abstract] [Full Text] [Related]

  • 16. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
    Freudenreich O, Henderson DC, Macklin EA, Evins AE, Fan X, Cather C, Walsh JP, Goff DC.
    J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921
    [Abstract] [Full Text] [Related]

  • 17. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB.
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [Abstract] [Full Text] [Related]

  • 19. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [Abstract] [Full Text] [Related]

  • 20. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M, Levi L, Burshtein S, Hagin M, Matei VP, Podea D, Micluția I, Tiugan A, Păcală B, Grecu IG, Noy A, Zamora D, Davis JM.
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.